CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Revenue Growth by Quarter and Year

Merck And Co Inc 's Revenue results by quarter and year




MRK Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 13,830.00 12,068.00 12,514.00
III Quarter September - 14,959.00 13,154.00 12,551.00
II Quarter June 15,035.00 14,593.00 11,402.00 10,872.00
I Quarter March 14,487.00 15,901.00 12,080.00 12,057.00
FY   29,522.00 59,283.00 48,704.00 47,994.00



MRK Revenue second quarter 2022 Y/Y Growth Comment
Merck and Co Inc reported Revenue growth of 3.03% year on year in the second quarter 2022, to $ 15,035.00 millions, this is lower than Merck And Co Inc 's recent average Revenue growth of 6.66%.

Looking into second quarter 2022 results within Major Pharmaceutical Preparations industry 156 other companies have achieved higher Revenue growth. While Merck And Co Inc ' s Revenue increase of 3.03% ranks overall at the positon no. 2665 in the second quarter 2022.




MRK Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 14.6 % -3.56 % 5.45 %
III Quarter September - 13.72 % 4.8 % 1.24 %
II Quarter June 3.03 % 27.99 % 4.87 % -7.55 %
I Quarter March -8.89 % 31.63 % 0.19 % 11.47 %
FY   - 21.72 % 1.48 % 2.46 %

Financial Statements
Merck And Co Inc 's second quarter 2022 Revenue $ 15,035.00 millions MRK's Income Statement
Merck And Co Inc 's second quarter 2021 Revenue $ 14,593.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Revenue Growth >>


MRK Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -7.55 % -8.26 % -0.29 %
III Quarter September - 2.51 % 15.37 % 15.44 %
II Quarter June 3.78 % -8.23 % -5.61 % -9.83 %
I Quarter March 4.75 % 31.76 % -3.47 % 1.6 %
FY (Year on Year)   - 21.72 % 1.48 % 2.46 %




Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #157
Healthcare Sector #400
Overall #2665

Revenue Y/Y Growth Statistics
High Average Low
112.1 % 6.66 % -10.57 %
(March 31, 2010)   (June 30. 2013)
Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #157
Healthcare Sector #400
Overall #2665
Revenue Y/Y Growth Statistics
High Average Low
112.1 % 6.66 % -10.57 %
(March 31, 2010)   (June 30. 2013)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Merck And Co Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
66.84 % 1.63 % -10.73 %
(Dec. 30, 2009)  


MRK's II. Quarter Q/Q Revenue Comment
Merck and Co Inc achieved in the II. Quarter 2022 above company average sequential Revenue growth of 3.78%, to $ 15,035.00 millions, from $14,487.00 millions in the first quarter.

Within Major Pharmaceutical Preparations industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 492.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #51
Healthcare Sector #107
Overall #492
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #51
Healthcare Sector #107
Overall #492
Revenue Q/Q Growth Statistics
High Average Low
66.84 % 1.63 % -10.73 %
(Dec. 30, 2009)  


MRK's II. Quarter Q/Q Revenue Comment
Merck and Co Inc achieved in the II. Quarter 2022 above company average sequential Revenue growth of 3.78%, to $ 15,035.00 millions, from $14,487.00 millions in the first quarter.

Within Major Pharmaceutical Preparations industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 492.


Merck And Co Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 58,311.00 $ 57,869.00 $ 59,283.00 $ 57,521.00 $ 55,716.00
Y / Y Revenue Growth (TTM) 4.66 % 10.17 % 21.72 % 17.03 % 14.77 %
Year on Year Revenue Growth Overall Ranking # 2019 # 0 # 2783 # 714 # 1744
Seqeuential Revenue Change (TTM) 0.76 % -2.39 % 3.06 % 3.24 % 6.08 %
Seq. Revenue Growth (TTM) Overall Ranking # 2640 # 0 # 2971 # 1614 # 560




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2023 period, Merck And Co Inc 's cumulative twelve months Revenue were $ 58,311 millions, company would post below average annual Revenue growth of 6.08% year on year, if the fiscal year would end at Jun 30 2023.
A slow-down in the Merck And Co Inc 's Revenue growth from the 14487% growth in Mar 31 2023.

In the Healthcare sector 294 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2019.

Revenue TTM Q/Q Growth Statistics
High Average Low
88.24 %
7.45 %
-7.58 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 126
Healthcare Sector # 295
Overall # 2019

Revenue TTM Y/Y Growth Statistics
High Average Low
88.24 %
7.45 %
-7.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 126
Sector # 369
S&P 500 # 2640
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2023 period, Merck And Co Inc 's cumulative twelve months Revenue were $ 58,311 millions, company would post below average annual Revenue growth of -7.58% year on year, if the fiscal year would end at Jun 30 2023.
A slow-down in the Merck And Co Inc 's Revenue growth from the 14487% growth in Mar 31 2023.

In the Healthcare sector 294 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2019.

Revenue TTM Q/Q Growth Statistics
High Average Low
88.24 %
7.45 %
-7.58 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 126
Healthcare Sector # 295
Overall # 2019

Revenue TTM Y/Y Growth Statistics
High Average Low
88.24 %
7.45 %
-7.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 126
Sector # 369
S&P 500 # 2640




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MRK's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for MRK's Competitors
Revenue Growth for Merck And Co Inc 's Suppliers
Revenue Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Eargo Inc 5.30%$ 5.299 millions
Iqvia Holdings Inc 5.28%$ 5.281 millions
Sientra Inc 5.12%$ 5.122 millions
Becton Dickinson And Company5.11%$ 5.107 millions
Zimmer Biomet Holdings Inc 4.93%$ 4.928 millions
Precision Optics Corporation Inc 4.81%$ 4.811 millions
Vaso Corporation4.79%$ 4.794 millions
Incyte Corporation4.74%$ 4.741 millions
Lifeloc Technologies Inc 4.60%$ 4.602 millions
Bio techne Corp4.60%$ 4.597 millions
Nevro Corp 4.41%$ 4.410 millions
Chemed Corporation4.24%$ 4.240 millions
National Healthcare Corp4.14%$ 4.136 millions
Fonar Corporation3.89%$ 3.885 millions
Healthlynked Corp 3.33%$ 3.334 millions
Align Technology inc 3.31%$ 3.306 millions
Bionexus Gene Lab Corp 3.29%$ 3.289 millions
Merck and Co Inc 3.03%$ 3.029 millions
Pediatrix Medical Group Inc 2.99%$ 2.992 millions
Aditxt Inc 2.92%$ 2.917 millions
Bolt Biotherapeutics Inc 2.87%$ 2.872 millions
Pressure Biosciences Inc 2.74%$ 2.743 millions
Neuronetics Inc 2.73%$ 2.725 millions
Jazz Pharmaceuticals Plc2.62%$ 2.620 millions
Davita Inc 2.52%$ 2.515 millions
Owens and Minor Inc 2.50%$ 2.497 millions
Teva Pharmaceutical Industries Limited2.43%$ 2.430 millions
Nuvasive Inc2.36%$ 2.363 millions
Myriad Genetics Inc 2.34%$ 2.342 millions
Innovage Holding Corp2.32%$ 2.322 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com